BCDA
Biocardia IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.41M
P/E Ratio
—
EPS
$-0.85
Beta
0.50
52W High
$2.45
52W Low
$0.78
50-Day MA
$1.06
200-Day MA
$1.30
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Biocardia Inc
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.67M |
| EBITDA | $-7.80M |
| Operating Margin | 0.00% |
| Return on Equity | -950.00% |
| Return on Assets | -252.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.10 |
| Price-to-Book | 12.35 |
| Price-to-Sales (TTM) | 2520.59 |
| EV/Revenue | 23.81 |
| EV/EBITDA | -3.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $14.88M |
| Float | $8.76M |
| % Insiders | 22.96% |
| % Institutions | 5.45% |
Historical Volatility
HV 10-Day
116.06%
HV 20-Day
99.36%
HV 30-Day
83.11%
HV 60-Day
64.19%
HV Rank
81.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026